Efficacy News and Research

RSS
Cerimon Pharmaceuticals acquires rights to develop and commercialize diclofenac sodium patch in Europe

Cerimon Pharmaceuticals acquires rights to develop and commercialize diclofenac sodium patch in Europe

Aduro BioTech raises funds through its Series A-1 financing

Aduro BioTech raises funds through its Series A-1 financing

Tokai Pharmaceuticals commences TOK-001 Phase 1/2 clinical trial for treatment of castration resistant prostate cancer

Tokai Pharmaceuticals commences TOK-001 Phase 1/2 clinical trial for treatment of castration resistant prostate cancer

Mesenchymal stem cells may be the key to healing diabetic foot ulcers

Mesenchymal stem cells may be the key to healing diabetic foot ulcers

Study suggests a new improved treatment option for children with Hurler's syndrome

Study suggests a new improved treatment option for children with Hurler's syndrome

Teva Pharmaceutical Industries amends patent infringement lawsuit against Momenta Pharmaceuticals/Sandoz

Teva Pharmaceutical Industries amends patent infringement lawsuit against Momenta Pharmaceuticals/Sandoz

Meditation training can have a positive effect on pain management

Meditation training can have a positive effect on pain management

Prostatitis is a psychoneuromuscular condition: Study

Prostatitis is a psychoneuromuscular condition: Study

EpiCept announces third quarter 2009 financial results

EpiCept announces third quarter 2009 financial results

Celling Technologies and SpineSmith team up to research adipose tissue derived stem cell applications

Celling Technologies and SpineSmith team up to research adipose tissue derived stem cell applications

VOA News examines conculsion of MIM Pan-African Malaria Conference

VOA News examines conculsion of MIM Pan-African Malaria Conference

Shire's INTUNIV for treating ADHD now available in the U.S.

Shire's INTUNIV for treating ADHD now available in the U.S.

CytRx reports financial results for the three months and nine months ended September 30, 2009

CytRx reports financial results for the three months and nine months ended September 30, 2009

ZeOmega announces alliance with Eldorado Computing to offer integrated care management solution

ZeOmega announces alliance with Eldorado Computing to offer integrated care management solution

NanoViricides to present data on its in vivo studies against influenza

NanoViricides to present data on its in vivo studies against influenza

BrainStorm Cell Therapeutics' approach for treating neurodegenerative diseases shown to be effective

BrainStorm Cell Therapeutics' approach for treating neurodegenerative diseases shown to be effective

Syneron Medical reports financial results for the third quarter of 2009

Syneron Medical reports financial results for the third quarter of 2009

Daval International receives award for its anti-inflammatory agent AIMSPRO

Daval International receives award for its anti-inflammatory agent AIMSPRO

Evaluation of DX-88 to resolve symptoms of acute HAE attacks to be presented

Evaluation of DX-88 to resolve symptoms of acute HAE attacks to be presented

Genetix Pharmaceuticals develops a gene therapy product to treat ALD

Genetix Pharmaceuticals develops a gene therapy product to treat ALD

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.